BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hagiwara S, Nishida N, Kudo M. Antiviral therapy for chronic hepatitis B: Combination of nucleoside analogs and interferon. World J Hepatol 2015; 7(23): 2427-2431 [PMID: 26483864 DOI: 10.4254/wjh.v7.i23.2427]
URL: https://www.wjgnet.com/1948-5182/full/v7/i23/2427.htm
Number Citing Articles
1
Pensiri Yosyingyong, Ratchada Viriyapong. Global stability and optimal control for a hepatitis B virus infection model with immune response and drug therapyJournal of Applied Mathematics and Computing 2019; 60(1-2): 537 doi: 10.1007/s12190-018-01226-x
2
Ozen Onen Sertoz, Ozlem Kuman Tuncel, Meltem Isikgoz Tasbakan, Husnu Pullukcu, Isabel Raika Durusoy Onmus, Tansu Yamazhan, Hayriye Elbi. Depression and anxiety disorders during pegylated interferon treatment in patients with chronic hepatitis BPsychiatry and Clinical Psychopharmacology 2017; 27(1): 47 doi: 10.1080/24750573.2017.1293251
3
Pensiri Yosyingyong, Ratchada Viriyapong. Global dynamics of multiple delays within-host model for a hepatitis B virus infection of hepatocytes with immune response and drug therapyMathematical Biosciences and Engineering 2023; 20(4): 7349 doi: 10.3934/mbe.2023319
4
Yadira Lobaina, Marie-Louise Michel. Chronic hepatitis B: Immunological profile and current therapeutic vaccines in clinical trialsVaccine 2017; 35(18): 2308 doi: 10.1016/j.vaccine.2017.03.049
5
Mingxing Huang, Yusheng Jie, Guoli Lin, Hong Shi, Xinhua Li, Xiangyong Li, Yuankai Wu, Yutian Chong. Long-Term Efficacy of Tenofovir Disoproxil Fumarate Therapy in Nucleos(t)ide-Experienced Chronic Hepatitis B PatientsClinical Drug Investigation 2016; 36(6): 471 doi: 10.1007/s40261-016-0392-0
6
Wu Guicheng, An Xuan, Xiang Yi, Wei Fang, Xia Lina, Zhong Qing, Du Biao, Liu Yong. Effect of Cytotoxic T Lymphocytes Induced by Recombinant Adeno-Associated Virus on Different Hepatitis B Virus GenesHepatitis Monthly 2016; 17(5) doi: 10.5812/hepatmon.42685
7
Mona Abdel-Hady, Deirdre A. Kelly. Encyclopedia of Gastroenterology2020; : 113 doi: 10.1016/B978-0-12-801238-3.65710-0
8
Shuqin Zhang, Shan Gao, Man Zhao, Yunxia Liu, Yanan Bu, Qiulei Jiang, Qiang Zhao, Lihong Ye, Xiaodong Zhang. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X proteinCancer Letters 2017; 392: 94 doi: 10.1016/j.canlet.2017.02.003
9
Kristie Bloom, Mohube Maepa, Abdullah Ely, Patrick Arbuthnot. Gene Therapy for Chronic HBV—Can We Eliminate cccDNA?Genes 2018; 9(4): 207 doi: 10.3390/genes9040207
10
Amedeo De Nicolò, Lucio Boglione, Jessica Cusato, Giovanna Fatiguso, Fabio Favata, Sarah Allegra, Giuseppe Cariti, Giovanni Di Perri, Antonio D'Avolio. Correlation between Entecavir Penetration in Peripheral Blood Mononuclear Cells and HBV DNA Decay during Treatment of HBeAg-Negative Chronic Hepatitis BAntiviral Therapy 2018; 23(4): 373 doi: 10.3851/IMP3207
11
Zhenbao Li, Lei Shang, Chang Liu, Panqin Ma, Chunnuan Wu, Wenjuan Zhang, Yinghua Sun, Yongjun Wang, Xiaohong Liu, Jin Sun. Evaluation of pharmacokinetics underlies the collaborated usage of lamivudine and oxymatrine in beagle dogsAsian Journal of Pharmaceutical Sciences 2016; 11(5): 641 doi: 10.1016/j.ajps.2016.02.007
12
Jialing Zhou, Xiaoning Wu, Wei Wei, Hong You, Jidong Jia, Yuanyuan Kong. A Meta-Analysis of the Efficacy of Interferon Monotherapy or Combined with Different Nucleos(t)ide Analogues for Chronic Hepatitis BInternational Journal of Environmental Research and Public Health 2016; 13(7): 730 doi: 10.3390/ijerph13070730
13
Karam Allali, Adil Meskaf, Abdessamad Tridane. Mathematical Modeling of the Adaptive Immune Responses in the Early Stage of the HBV InfectionInternational Journal of Differential Equations 2018; 2018: 1 doi: 10.1155/2018/6710575